Xiaoyu Xie

2PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 02, 2026
Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancer.

|Apr 02, 2024
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial.

Huabin Hu, Jianwei Zhang, Yunfeng Li

Pageof 1

Frequent Collaborators

1 joint publications

Huabin Hu

1 joint publications

Jianwei Zhang

1 joint publications

Ziqiang Wang

1 joint publications

Hui Wang